Search by Drug Name or NDC

    NDC 62011-0382-01 Guaifenesin Extended Release 600 mg 600 mg/1 Details

    Guaifenesin Extended Release 600 mg 600 mg/1

    Guaifenesin Extended Release 600 mg is a ORAL TABLET, EXTENDED RELEASE in the HUMAN OTC DRUG category. It is labeled and distributed by Strategic Sourcing Services LLC. The primary component is GUAIFENESIN.

    Product Information

    NDC 62011-0382
    Product ID 62011-0382_bd3e14ab-7aa6-4646-a757-17aa99ee71e7
    Associated GPIs 43200010007420
    GCN Sequence Number 071885
    GCN Sequence Number Description guaifenesin TAB ER 12H 600 MG ORAL
    HIC3 B3J
    HIC3 Description EXPECTORANTS
    GCN 35905
    HICL Sequence Number 000271
    HICL Sequence Number Description GUAIFENESIN
    Brand/Generic Generic
    Proprietary Name Guaifenesin Extended Release 600 mg
    Proprietary Name Suffix n/a
    Non-Proprietary Name Guaifenesin
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 600
    Active Ingredient Units mg/1
    Substance Name GUAIFENESIN
    Labeler Name Strategic Sourcing Services LLC
    Pharmaceutical Class Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA209215
    Listing Certified Through 2024-12-31

    Package

    NDC 62011-0382-01 (62011038201)

    NDC Package Code 62011-0382-1
    Billing NDC 62011038201
    Package 4 BLISTER PACK in 1 CARTON (62011-0382-1) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
    Marketing Start Date 2019-10-17
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.32501
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description HM MUCUS RELIEF ER 600 MG TAB
    Pharmacy Type Indicator C/I
    OTC Y
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis

    Standard Product Labeling (SPL)/Prescribing Information SPL d2c4ea2f-dbdc-40e1-96df-a0193560e9ea Details

    Revised: 1/2022